Skip to main content
The BMJ logoLink to The BMJ
. 1988 Oct 8;297(6653):900–901. doi: 10.1136/bmj.297.6653.900

Suppression of ovulation by transdermal oestradiol patches.

N R Watson 1, J W Studd 1, A F Riddle 1, M Savvas 1
PMCID: PMC1834440  PMID: 3140971

Full text

PDF
900

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chetkowski R. J., Meldrum D. R., Steingold K. A., Randle D., Lu J. K., Eggena P., Hershman J. M., Alkjaersig N. K., Fletcher A. P., Judd H. L. Biologic effects of transdermal estradiol. N Engl J Med. 1986 Jun 19;314(25):1615–1620. doi: 10.1056/NEJM198606193142505. [DOI] [PubMed] [Google Scholar]
  2. Greenblatt R. B., Asch R. H., Mahesh V. B., Bryner J. R. Implantation of pure crystalline pellets of estradiol for conception control. Am J Obstet Gynecol. 1977 Mar 1;127(5):520–524. doi: 10.1016/0002-9378(77)90447-1. [DOI] [PubMed] [Google Scholar]
  3. Magos A. L., Collins W. P., Studd J. W. Effects of subcutaneous oestradiol implants on ovarian activity. Br J Obstet Gynaecol. 1987 Dec;94(12):1192–1198. doi: 10.1111/j.1471-0528.1987.tb02321.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES